SEARCH

SEARCH BY CITATION

References

  • Augood S. J., Faull R. L., Love D. R. and Emson P. C. (1996) Reduction in enkephalin and substance P messenger RNA in the striatum of early grade Huntington's disease: a detailed cellular in situ hybridization study. Neuroscience 72, 10231036.
  • Augood S. J., Faull R. L. and Emson P. C. (1997) Dopamine D1 and D2 receptor gene expression in the striatum in Huntington's disease. Ann. Neurol. 42, 215221.
  • Bibb J. A., Yan Z., Svenningsson P., Snyder G. L., Pieribone V. A., Horiuchi A., Nairn A. C., Messer A. and Greengard P. (2000) Severe deficiencies in dopamine signaling in presymptomatic Huntington's disease mice. Proc. Natl Acad. Sci. USA 97, 68096814.
  • Blaustein M. P. and Lederer W. J. (1999) Sodium/calcium exchange: its physiological implications. Physiol. Rev. 79, 763854.
  • Brene S., Herrera-Marschitz M., Persson H. and Lindefors N. (1994) Expression of mRNAs encoding dopamine receptors in striatal regions is differentially regulated by midbrain and hippocampal neurons. Brain Res. Mol Brain Res. 21, 274282.
  • Castets F., Bartoli M., Barnier J. V. et al. (1996) A novel calmodulin-binding protein, belonging to the WD-repeat family, is localized in dendrites of a subset of CNS neurons. J. Cell Biol. 134, 10511062.
  • Cha J. H., Kosinski C. M., Kerner J. A., Alsdorf S. A., Mangiarini L., Davies S. W., Penney J. B., Bates G. P. and Young A. B. (1998) Altered brain neurotransmitter receptors in transgenic mice expressing a portion of an abnormal human huntington disease gene. Proc. Natl Acad. Sci. USA 95, 64806485.
  • Cha J. H., Frey A. S., Alsdorf S. A., Kerner J. A., Kosinski C. M., Mangiarini L., Penney J. B. Jr, Davies S. W., Bates G. P. and Young A. B. (1999) Altered neurotransmitter receptor expression in transgenic mouse models of Huntington's disease. Philos. Trans. R. Soc. Lond. B Biol. Sci. 354, 981989.
  • De Chaldee M., Gaillard M. C., Bizat N., Buhler J. M., Manzoni O., Bockaert J., Hantraye P., Brouillet E. and Elalouf J. M. (2003) Quantitative assessment of transcriptome differences between brain territories. Genome Res. 13, 16461653.
  • Chan E. Y., Luthi-Carter R., Strand A. et al. (2002) Increased huntingtin protein length reduces the number of polyglutamine-induced gene expression changes in mouse models of Huntington's disease. Hum. Mol. Genet. 11, 19391951.
  • Chang C. W., Tsai C. W., Wang H. F. et al. (2004) Identification of a developmentally regulated striatum-enriched zinc-finger gene, Nolz-1, in the mammalian brain. Proc. Natl Acad. Sci. USA 101, 26132618.
  • Van Dellen A., Welch J., Dixon R. M., Cordery P., York D., Styles P., Blakemore C. and Hannan A. J. (2000) N-Acetylaspartate and DARPP-32 levels decrease in the corpus striatum of Huntington's disease mice. Neuroreport 11, 37513757.
  • DiFiglia M., Sapp E., Chase K., Schwarz C., Meloni A., Young C., Martin E., Vonsattel J. P., Carraway R. and Reeves S. A. (1995) Huntingtin is a cytoplasmic protein associated with vesicles human and rat brain neurons. Neuron 14, 10751081.
  • Dunah A. W., Wyszynski M., Martin D. M., Sheng M. and Standaert D. G. (2000) alpha-actinin-2 in rat striatum: localization and interaction with NMDA glutamate receptor subunits. Brain Res. Mol Brain Res. 79, 7787.
  • Ehrlich M. E., Kurihara T. and Greengard P. (1990) Rat DARPP-32: cloning, sequencing, and characterization of the cDNA. J. Mol Neurosci. 2, 110.
  • Falk J. D., Vargiu P., Foye P. E., Usui H., Perez J., Danielson P. E., Lerner D. L., Bernal J. and Sutcliffe J. G. (1999) Rhes: a striatal-specific Ras homolog related to Dexras1. J. Neurosci. Res. 57, 782788.
  • Fornaretto M. G., Caccia C., Caron M. G. and Fariello R. G. (1993) Dopamine receptors status after unilateral nigral 6-OHDA lesion. Autoradiographic and in situ hybridization study in the rat brain. Mol Chem. Neuropathol. 19, 147162.
  • Fremeau R. T. J., Duncan G. E., Fornaretto M. G., Dearry A., Gingrich J. A., Breese G. R. and Caron M. G. (1991) Localization of D1 dopamine receptor mRNA in brain supports a role in cognitive, affective, and neuroendocrine aspects of dopaminergic neurotransmission. Proc. Natl Acad. Sci. USA 88, 37723776.
  • Fujishige K., Kotera J. and Omori K. (1999) Striatum- and testis-specific phosphodiesterase PDE10A isolation and characterization of a rat PDE10A. Eur. J. Biochem. 266, 11181127.
  • Girault J. A., Horiuchi A., Gustafson E. L., Rosen N. L. and Greengard P. (1990) Differential expression of ARPP-16 and ARPP-19, two highly related cAMP-regulated phosphoproteins, one of which is specifically associated with dopamine-innervated brain regions. J. Neurosci. 10, 11241133.
  • Glatt C. E. and Snyder S. H. (1993) Cloning and expression of an adenylyl cyclase localized to the corpus striatum. Nature 363, 679680.
  • Goedert M. and Hunt S. P. (1987) The cellular localization of preprotachykinin A messenger RNA in the bovine nervous system. Neuroscience 22, 983992.
  • Goto K. and Kondo H. (1999) Diacylglycerol kinase in the central nervous system – molecular heterogeneity and gene expression. Chem. Phys. Lipids 98, 109117.
  • Graybiel A. M. (1995) The basal ganglia. Trends Neurosci. 18, 6062.
  • Hanson G. R. and Keefe K. A. (1999) Dopamine D-1 regulation of caudate neurotensin mRNA in the presence or absence of the nigrostriatal dopamine pathway. Brain Res. Mol. Brain Res. 66, 111121.
  • Hansson O., Petersen A., Leist M., Nicotera P., Castilho R. F. and Brundin P. (1999) Transgenic mice expressing a Huntington's disease mutation are resistant to quinolinic acid-induced striatal excitotoxicity. Proc. Natl Acad. Sci. USA 96, 87278732.
  • Hebb A. L., Robertson H. A. and Denovan-Wright E. M. (2004) Striatal phosphodiesterase mRNA and protein levels are reduced in Huntington's disease transgenic mice prior to the onset of motor symptoms. Neuroscience 123, 967981.
  • Hemmings H. C. Jr and Greengard P. (1989) ARPP-21, a cyclic AMP-regulated phosphoprotein enriched in dopamine-innervated brain regions. I. Purification and characterization of the protein from bovine caudate nucleus. J. Neurosci. 9, 851864.
  • Hersch S. M., Ciliax B. J., Gutekunst C. A., Rees H. D., Heilman C. J., Yung K. K., Bolam J. P., Ince E., Yi H. and Levey A. I. (1995) Electron microscopic analysis of D1 and D2 dopamine receptor proteins in the dorsal striatum and their synaptic relationships with motor corticostriatal afferents. J. Neurosci. 15, 52225237.
  • Herve D., Levi-Strauss M., Marey-Semper I., Verney C., Tassin J. P., Glowinski J. and Girault J. A. (1993) G(olf) and Gs in rat basal ganglia: possible involvement of G(olf) in the coupling of dopamine D1 receptor with adenylyl cyclase. J. Neurosci. 13, 22372248.
  • Huntington's Disease Collaborative Research Group. (1993) A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. The Huntington's Disease Collaborative Research Group. Cell 72, 971983.
  • Hwang C. K., D'Souza U. M., Eisch A. J., Yajima S., Lammers C. H., Yang Y., Lee S. H., Kim Y. M., Nestler E. J. and Mouradian M. M. (2001) Dopamine receptor regulating factor, DRRF: a zinc finger transcription factor. Proc. Natl Acad. Sci. USA 98, 75587563.
  • Irizarry R. A., Bolstad B. M., Collin F., Cope L. M., Hobbs B. and Speed T. P. (2003) Summaries of Affymetrix GeneChip probe level data. Nucleic Acids Res. 31, e15.
  • Janis L. S., Cassidy R. M. and Kromer L. F. (1999) Ephrin-A binding and EphA receptor expression delineate the matrix compartment of the striatum. J. Neurosci. 19, 49624971.
  • Kaelin-Lang A., Liniger P., Probst A., Lauterburg T. and Burgunder J. M. (2000) Adenosine A2A receptor gene expression in the normal striatum and after 6-OH-dopamine lesion. J. Neural Transm 107, 851859.
  • Kawasaki H., Springett G. M., Toki S. et al. (1998) A Rap guanine nucleotide exchange factor enriched highly in the basal ganglia. Proc. Natl Acad. Sci. USA 95, 13 27813 283.
  • Krezel W., Kastner P. and Chambon P. (1999) Differential expression of retinoid receptors in the adult mouse central nervous system. Neuroscience 89, 12911300.
  • Le Moine C., Kieffer B., Gaveriaux-Ruff C., Befort K. and Bloch B. (1994) Delta-opioid receptor gene expression in the mouse forebrain: localization in cholinergic neurons of the striatum. Neuroscience 62, 635640.
  • Levesque D., Martres M. P., Diaz J., Griffon N., Lammers C. H., Sokoloff P. and Schwartz J. C. (1995) A paradoxical regulation of the dopamine D3 receptor expression suggests the involvement of an anterograde factor from dopamine neurons. Proc. Natl Acad. Sci. USA 92, 17191723.
  • Lockhart D. J., Dong H., Byrne M. C. et al. (1996) Expression monitoring by hybridization to high-density oligonucleotide arrays. Nat. Biotechnol. 14, 16751680.
  • Lombroso P. J., Naegele J. R., Sharma E. and Lerner M. (1993) A protein tyrosine phosphatase expressed within dopaminoceptive neurons of the basal ganglia and related structures. J. Neurosci. 13, 30643074.
  • Luthi-Carter R., Strand A., Peters N. L. et al. (2000) Decreased expression of striatal signaling genes in a mouse model of Huntington's disease. Hum. Mol. Genet. 9, 12591271.
  • Luthi-Carter R., Hanson S. A., Strand A. D. et al. (2002a) Dysregulation of gene expression in the R6/2 model of polyglutamine disease: parallel changes in muscle and brain. Hum. Mol. Genet. 11, 19111926.
  • Luthi-Carter R., Strand A. D., Hanson S. A. et al. (2002b) Polyglutamine and transcription: gene expression changes shared by DRPLA and Huntington's disease mouse models reveal context-independent effects. Hum. Mol. Genet. 11, 19271937.
  • Magdaleno S., Northcutt G. M., Curran T. and Kurschner C. (2002) mPPP1R16B is a novel mouse protein phosphatase 1 targeting subunit whose mRNA is located in cell bodies and dendrites of neurons in four distinct regions of the brain. Brain Res. Gene Expr. Patterns 1, 143149.
  • Mangiarini L., Sathasivam K., Seller M. et al. (1996) Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice. Cell 87, 493506.
  • Mansour A., Fox C. A., Burke S., Meng F., Thompson R. C., Akil H. and Watson S. J. (1994) Mu, delta, and kappa opioid receptor mRNA expression in the rat CNS: an in situ hybridization study. J. Comp. Neurol. 350, 412438.
  • Marqueze-Pouey B., Wisden W., Malosio M. L. and Betz H. (1991) Differential expression of synaptophysin and synaptoporin mRNAs in the postnatal rat central nervous system. J. Neurosci. 11, 33883397.
  • Meador-Woodruff J. H., Mansour A., Bunzow J. R., Van Tol H. H., Watson S. J. Jr and Civelli O. (1989) Distribution of D2 dopamine receptor mRNA in rat brain. Proc. Natl Acad. Sci. USA 86, 76257628.
  • Menalled L., Zanjani H., MacKenzie L., Koppel A., Carpenter E., Zeitlin S. and Chesselet M. F. (2000) Decrease in striatal enkephalin mRNA in mouse models of Huntington's disease. Exp. Neurol. 162, 328342.
  • Mendez J. S. and Finn B. W. (1975) Use of 6-hydroxydopamine to create lesions in catecholamine neurons in rats. J. Neurosurg. 42, 166173.
  • Mizushima K., Miyamoto Y., Tsukahara F., Hirai M., Sakaki Y. and Ito T. (2000) A novel G-protein-coupled receptor gene expressed in striatum. Genomics 69, 314321.
  • Mokry J. (1995) Experimental models and behavioural tests used in the study of Parkinson's disease. Physiol. Res. 44, 143150.
  • Myers R. H., Vonsattel J. P., Stevens T. J., Cupples L. A., Richardson E. P., Martin J. B. and Bird E. D. (1988) Clinical and neuropathologic assessment of severity in Huntington's disease. Neurology 38, 341347.
  • Napolitano M., Centonze D., Calce A., Picconi B., Spiezia S., Gulino A., Bernardi G. and Calabresi P. (2002) Experimental parkinsonism modulates multiple genes involved in the transduction of dopaminergic signals in the striatum. Neurobiol. Dis. 10, 387395.
  • Naver B., Stub C., Moller M., Fenger K., Hansen A. K., Hasholt L. and Sorensen S. A. (2003) Molecular and behavioral analysis of the R6/1 Huntington's disease transgenic mouse. Neuroscience 122, 10491057.
  • Ouimet C. C., Miller P. E., Hemmings H. C. Jr, Walaas S. I. and Greengard P. (1984) DARPP-32, a dopamine- and adenosine 3′: 5′-monophosphate-regulated phosphoprotein enriched in dopamine-innervated brain regions. III. Immunocytochemical localization. J. Neurosci. 4, 111124.
  • Panov A. V., Gutekunst C. A., Leavitt B. R., Hayden M. R., Burke J. R., Strittmatter W. J. and Greenamyre J. T. (2002) Early mitochondrial calcium defects in Huntington's disease are a direct effect of polyglutamines. Nat. Neurosci. 5, 731736.
  • Panov A. V., Burke J. R., Strittmatter W. J. and Greenamyre J. T. (2003) In vitro effects of polyglutamine tracts on Ca2+-dependent depolarization of rat and human mitochondria: relevance to Huntington's disease. Arch. Biochem. Biophys. 410, 16.
  • Parent A. (1990) Extrinsic connections of the basal ganglia. Trends Neurosci. 13, 254258.
  • Polli J. W. and Kincaid R. L. (1992) Molecular cloning of DNA encoding a calmodulin-dependent phosphodiesterase enriched in striatum. Proc. Natl Acad. Sci. USA 89, 11 07911 083.
  • Richfield E. K., Maguire-Zeiss K. A., Cox C., Gilmore J. and Voorn P. (1995) Reduced expression of preproenkephalin in striatal neurons from Huntington's disease patients. Ann. Neurol. 37, 335343.
  • Rodrigues N. R., Theodosiou A. M., Nesbit M. A., Campbell L., Tandle A. T., Saranath D. and Davies K. E. (2000) Characterization of Ngef, a novel member of the Dbl family of genes expressed predominantly in the caudate nucleus. Genomics 65, 5361.
  • Ross C. A., Becher M. W., Colomer V., Engelender S., Wood J. D. and Sharp A. H. (1997) Huntington's disease and dentatorubral-pallidoluysian atrophy: proteins, pathogenesis and pathology. Brain Pathol. 7, 10031016.
  • Ruat M., Traiffort E., Arrang J. M., Tardivel-Lacombe J., Diaz J., Leurs R. and Schwartz J. C. (1993) A novel rat serotonin (5-HT6) receptor: molecular cloning, localization and stimulation of cAMP accumulation. Biochem. Biophys. Res. Commun. 193, 268276.
  • Shivers B. D., Harlan R. E., Romano G. J., Howells R. D. and Pfaff D. W. (1986) Cellular localization of proenkephalin mRNA in rat brain: gene expression in the caudate-putamen and cerebellar cortex. Proc. Natl Acad. Sci. USA 83, 62216225.
  • Sivam S. P., Breese G. R., Krause J. E., Napier T. C., Mueller R. A. and Hong J. S. (1987) Neonatal and adult 6-hydroxydopamine-induced lesions differentially alter tachykinin and enkephalin gene expression. J. Neurochem. 49, 16231633.
  • Smith J. A., Leslie F. M., Broide R. S. and Loughlin S. E. (1993) Long-term changes in striatal opioid systems after 6-hydroxydopamine lesion of rat substantia nigra. Neuroscience 55, 935951.
  • Smits S. M., Terwisscha van Scheltinga A. F., Van Der Linden A. J., Burbach J. P. and Smidt M. P. (2004) Species differences in brain pre-pro-neurotensin/neuromedin N mRNA distribution: the expression pattern in mice resembles more closely that of primates than rats. Brain Res. Mol. Brain Res. 125, 2228.
  • Soghomonian J. J. (1993) Effects of neonatal 6-hydroxydopamine injections on glutamate decarboxylase, preproenkephalin and dopamine D2 receptor mRNAs in the adult rat striatum. Brain Res. 621, 249259.
  • Stanwood G. D., McElligot S., Lu L. and McGonigle P. (1997) Ontogeny of dopamine D3 receptors in the nucleus accumbens of the rat. Neurosci. Lett. 223, 1316.
  • Starr M. S. (1995) Glutamate/dopamine D1/D2 balance in the basal ganglia and its relevance to Parkinson's disease. Synapse 19, 264293.
  • Sutcliffe J. G., Foye P. E., Erlander M. G., Hilbush B. S., Bodzin L. J., Durham J. T. and Hasel K. W. (2000) TOGA: an automated parsing technology for analyzing expression of nearly all genes. Proc. Natl Acad. Sci. USA 97, 19761981.
  • Svenningsson P., Le Moine C., Kull B., Sunahara R., Bloch B. and Fredholm B. B. (1997) Cellular expression of adenosine A2A receptor messenger RNA in the rat central nervous system with special reference to dopamine innervated areas. Neuroscience 80, 11711185.
  • Takahashi K., Liu F. C., Hirokawa K. and Takahashi H. (2003) Expression of Foxp2, a gene involved in speech and language, in the developing and adult striatum. J. Neurosci. Res. 73, 6172.
  • Tang T. S., Slow E., Lupu V., Stavrovskaya I. G., Sugimori M., Llinas R., Kristal B. S., Hayden M. R. and Bezprozvanny I. (2005) Disturbed Ca2+ signaling and apoptosis of medium spiny neurons in Huntington's disease. Proc. Natl Acad. Sci. USA 102, 26022607.
  • Thomas E. A., Danielson P. E. and Sutcliffe J. G. (1998) RGS9: a regulator of G-protein signalling with specific expression in rat and mouse striatum. J. Neurosci. Res. 52, 118124.
  • Thomas E. A., Foye P. E., Alvarez C. E., Usui H. and Sutcliffe J. G. (2001) Insulin receptor substrate protein p53 localization in rats suggests mechanism for specific polyglutamine neurodegeneration. Neurosci. Lett. 309, 145148.
  • Thomas E. A., George R. C., Danielson P. E., Nelson P. A., Warren A. J., Lo D. and Sutcliffe J. G. (2003) Antipsychotic drug treatment alters expression of mRNAs encoding lipid metabolism-related proteins. Mol. Psychiatry 8, 983993.
  • Ulas J. and Cotman C. W. (1996) Dopaminergic denervation of striatum results in elevated expression of NR2A subunit. Neuroreport 7, 17891793.
  • Ullmer C., Engels P., Abdel'Al S. and Lubbert H. (1996) Distribution of 5-HT4 receptor mRNA in the rat brain. Naunyn Schmiedebergs Arch. Pharmacol. 354, 210212.
  • Usui H., Falk J. D., Dopazo A., De Lecea L., Erlander M. G. and Sutcliffe J. G. (1994) Isolation of clones of rat striatum-specific mRNAs by directional tag PCR subtraction. J. Neurosci. 14, 49154926.
  • Vonsattel J. P., Myers R. H., Stevens T. J., Ferrante R. J., Bird E. D. and Richardson E. P. J. (1985) Neuropathological classification of Huntington's disease. J. Neuropathol. Exp. Neurol. 44, 559577.
  • Wang H. F. and Liu F. C. (2001) Developmental restriction of the LIM homeodomain transcription factor Islet-1 expression to cholinergic neurons in the rat striatum. Neuroscience 103, 9991016.
  • Watson J. B., Coulter P. M. N., Margulies J. E., De Lecea L., Danielson P. E., Erlander M. G. and Sutcliffe J. G. (1994) G-protein gamma 7 subunit is selectively expressed in medium-sized neurons and dendrites of the rat neostriatum. J. Neurosci. Res. 39, 108116.
  • Yu F. H., Westenbroek R. E., Silos-Santiago I. et al. (2003) Sodium channel beta4, a new disulfide-linked auxiliary subunit with similarity to beta2. J. Neurosci. 23, 75777585.